First Horizon Advisors’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.73K | Sell |
24
-11
| -31% | -$1.25K | ﹤0.01% | 1976 |
|
|
2025
Q1 | $3.68K | Sell |
35
-32
| -48% | -$3.37K | ﹤0.01% | 1864 |
|
|
2024
Q4 | $7.18K | Hold |
67
| – | – | ﹤0.01% | 1715 |
|
|
2024
Q3 | $6.71K | Hold |
67
| – | – | ﹤0.01% | 1735 |
|
|
2024
Q2 | $5.65K | Buy |
67
+35
| +109% | +$2.95K | ﹤0.01% | 1725 |
|
|
2024
Q1 | $2.34K | Buy |
+32
| New | +$2.34K | ﹤0.01% | 1992 |
|
|
2022
Q3 | – | Sell |
-11
| Closed | -$1K | – | 2373 |
|
|
2022
Q2 | $1K | Buy |
+11
| New | +$1K | ﹤0.01% | 2225 |
|
|
2020
Q3 | – | Sell |
-10
| Closed | – | – | 1490 |
|
|
2020
Q2 | $0 | Sell |
10
-11
| -52% | – | ﹤0.01% | 1437 |
|
|
2020
Q1 | $0 | Sell |
21
-243
| -92% | – | ﹤0.01% | 1481 |
|
|
2019
Q4 | $17K | Hold |
264
| – | – | ﹤0.01% | 915 |
|
|
2019
Q3 | $16K | Sell |
264
-106
| -29% | -$6.42K | ﹤0.01% | 926 |
|
|
2019
Q2 | $26K | Buy |
+370
| New | +$26K | ﹤0.01% | 781 |
|